Fig. 1From: Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetesEPC number evaluation. Flow-cytometry analysis scatter plots to assess EPC number. Within the lymphomonocyte population (a) CD34 (b) and CD133 (c) positive cells were gated and evaluated for the expression of KDR to identify CD34+/CD133+/KDR+ cells (d)Back to article page